These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 22406987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, Fan X, Aurora SK, Brandes JL, Fei K, Beebe L, Lines C, Krucoff MW.
    Headache; 2012 Feb; 52(2):224-35. PubMed ID: 22221076
    [Abstract] [Full Text] [Related]

  • 3. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ, Cleves C.
    Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
    Cui XP, Ye JX, Lin H, Mu JS, Lin M.
    Pain Pract; 2015 Feb; 15(2):124-31. PubMed ID: 24382126
    [Abstract] [Full Text] [Related]

  • 6. Treatment of migraine: update on new therapies.
    Magis D, Schoenen J.
    Curr Opin Neurol; 2011 Jun; 24(3):203-10. PubMed ID: 21464715
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
    Connor KM, Aurora SK, Loeys T, Ashina M, Jones C, Giezek H, Massaad R, Williams-Diaz A, Lines C, Ho TW.
    Headache; 2011 Jan; 51(1):73-84. PubMed ID: 21070230
    [Abstract] [Full Text] [Related]

  • 9. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
    Edvinsson L, Linde M.
    Lancet; 2010 Aug 21; 376(9741):645-55. PubMed ID: 20416945
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ, Regan CP, Edvinsson L, Hargreaves RJ, Kane SA.
    J Cardiovasc Pharmacol; 2010 May 21; 55(5):518-21. PubMed ID: 20164785
    [Abstract] [Full Text] [Related]

  • 13. Molecule of the month. Telcagepant.
    Drug News Perspect; 2009 Mar 21; 22(2):115. PubMed ID: 19330169
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
    Moore EL, Burgey CS, Paone DV, Shaw AW, Tang YS, Kane SA, Salvatore CA.
    Eur J Pharmacol; 2009 Jan 14; 602(2-3):250-4. PubMed ID: 19084002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.